AGHOL:BISTAG Anadolu Grubu Holding Anonim Sirketi Analysis
Data as of 2026-06-22 - not real-time
TRY 34.10
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at 34.1 TRY, comfortably above its 20‑day (33.49), 50‑day (32.98) and 200‑day (30.12) simple moving averages, indicating a short‑term bullish bias. RSI sits at 54, just above the neutral zone, and the MACD line (0.197) is above its signal (0.138), reinforcing the bullish momentum. However, the price is more than three times the DCF fair value of 10.25 TRY, yielding a 36% upside/downside metric that flags significant overvaluation. The company’s volatility is high at 41% over the past 30 days, while its beta is low (~0.15), suggesting that most risk is idiosyncratic rather than market‑driven. A solid dividend yield of 2.05% with a payout ratio under 50% points to a sustainable payout, yet the firm carries a debt‑to‑equity of 46.5 and a modest operating margin of 2.4%, highlighting leverage and profitability concerns. Cash flow remains robust (operating cash flow ~80 bn TRY) but free cash flow is thin, underscoring the need for disciplined capital allocation. Given the bullish technical setup, overvalued fundamentals, high volatility, and macro‑economic exposure in Turkey, the outlook is mixed: short‑term momentum may hold, but long‑term upside appears limited.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above SMAs, MACD bullish)
- Overvaluation relative to DCF fair value
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong dividend yield with sustainable payout
- Elevated leverage and thin free cash flow
- Mixed growth outlook driven by forward EPS expectations
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant price premium over intrinsic value
- High debt load and low profitability margins
- Exposure to Turkish macro‑economic and regulatory environment
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin0.50%
P/E Ratio0.2
ROE6.72%
ROA3.84%
Debt/Equity46.52
P/B Ratio0.7
Op. Cash FlowTRY80.7B
Free Cash FlowTRY6.9B
Industry P/E31.4
Technical Analysis
TrendBullish
RSI54.2
SupportTRY 31.52
ResistanceTRY 35.26
MA 20TRY 33.49
MA 50TRY 32.98
MA 200TRY 30.12
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair ValueTRY 10.25
Target PriceTRY 46.52
Upside/Downside36.43%
GradeOvervalued
TypeGrowth
Dividend Yield2.05%
Risk Assessment
Beta0.15
Volatility41.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.